Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA,
Curr Allergy Asthma Rep. 2014 Sep;14(9):461. doi: 10.1007/s11882-014-0461-5.
The vitamin D hypothesis postulates that lower vitamin D levels are causally associated with increased asthma risk and asthma severity. Multiple epidemiological studies have shown an inverse relationship between circulating vitamin D levels (in the form of 25-hydroxy vitamin D) and asthma severity and control and lung function. However, in the recently published vitamin D and asthma (VIDA) study, vitamin D supplementation failed to show an improvement in asthma control in adults. This article reviews the current epidemiological and trial evidence for vitamin D and asthma and explores some of the possible alternative explanations for previous findings (including "reverse causation" and the importance of studying children and adults). We also address some of the unique challenges of conducting vitamin D trials and potential ways to address them. Finally, I will argue for further clinical trials of vitamin D in asthma, especially in children, using knowledge gained from the VIDA trial.
维生素 D 假说认为,维生素 D 水平较低与哮喘风险增加和哮喘严重程度相关。多项流行病学研究表明,循环维生素 D 水平(以 25-羟维生素 D 的形式存在)与哮喘严重程度和控制以及肺功能呈负相关。然而,在最近发表的维生素 D 和哮喘(VIDA)研究中,维生素 D 补充未能显示出对成年人哮喘控制的改善。本文综述了目前关于维生素 D 和哮喘的流行病学和试验证据,并探讨了先前研究结果的一些可能的替代解释(包括“反向因果关系”以及研究儿童和成人的重要性)。我们还讨论了进行维生素 D 试验的一些独特挑战以及解决这些挑战的潜在方法。最后,我将根据 VIDA 试验的结果,主张在哮喘中特别是在儿童中进一步进行维生素 D 的临床试验。